• Tuberculosis (TB) is now the leading infectious disease killer worldwide, according to the World Health Organization (WHO).
• The disease impacts 10 million people and results in 1.5 million deaths each year, with Africa and Southeast Asia being the most affected regions.
• TB is caused by Mycobacterium tuberculosis and spreads through airborne particles from coughs or sneezes.
• Symptoms include persistent cough, chest pain, and weight loss, which can lead to severe complications if not treated.
• The emergence of multi-drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) complicates treatment and emphasizes adherence to antibiotic regimens.
• Global initiatives are intensifying efforts on vaccination, improved diagnostics, and innovative therapies to combat TB.
• The Bacillus Calmette-Guérin (BCG) vaccine offers some protection, particularly in children, while new drugs aim to enhance treatment adherence.
• The WHO’s End TB Strategy aims for a 95% reduction in TB deaths by 2035, highlighting the need for increased funding and research.
Tuberculosis (TB) is re-emerging as the top infectious disease killer globally, as highlighted by the World Health Organization (WHO). Despite being preventable and curable, TB affects 10 million people and causes 1.5 million deaths annually, with the highest incidence in Africa and Southeast Asia. The disease is caused by Mycobacterium tuberculosis and spreads through airborne transmission from coughs or sneezes.
Symptoms include persistent cough, chest pain, and weight loss, often escalating to severe complications if untreated. The rise of multi-drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) underscores the critical need for adherence to antibiotic regimens and poses significant treatment challenges.
Efforts to combat TB are intensifying, focusing on vaccination, improved diagnostics, and innovative therapies. The Bacillus Calmette-Guérin (BCG) vaccine provides some protection, particularly for children, and new drugs aim to improve treatment adherence.
Global health organizations emphasize the urgency of collaborative strategies, with the WHO’s End TB Strategy targeting a 95% reduction in TB deaths by 2035. Enhanced funding and research are crucial to tackling this resurgent threat and securing a healthier future.
